Fred M Powell
CIK 1331339 · Chief Financial Officer · last filed 2025-11-17
Fred M Powell is a Chief Financial Officer who has filed 37 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for LVTX, was dated Nov 17, 2025. Across all open-market trades the lifetime net is +$673.0K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
37
$673.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LAVA Therapeutics NV (LVTX) Delisted | Chief Financial Officer | 0 | $1.74 | $0 | $0 | 2 | 2025-11-17 |
| ANTARES PHARMA, INC. (ATRS) Delisted | Executive Vice President & CFO | 791,036 | $5.59 | $4.42M | $612.5K | 17 | 2022-03-04 |
| Celator Pharmaceuticals Inc (CPXX) Delisted | VP and Chief Financial Officer | 0 | — | — | $46.3K | 10 | 2016-07-12 |
| BMP Sunstone CORP (BJGP) Delisted | Chief Financial Officer | 2,500 | — | — | $14.1K | 5 | 2009-08-17 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-17 | LAVA Therapeutics NV (LVTX) Delisted | Disp (D) | −65,000 | $0 | EDGAR |
| 2025-02-18 | LAVA Therapeutics NV (LVTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | — | Disp (D) | −915,270 | -$5.13M | |
| 2022-03-04 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +16,274 | -$43.7K | EDGAR |
| 2022-02-18 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +13,110 | -$42.1K | EDGAR |
| 2021-06-14 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +56,766 | $250.0K | EDGAR |
| 2021-06-10 | ANTARES PHARMA, INC. (ATRS) Delisted | Tax (F) | −12,045 | -$52.9K | EDGAR |
| 2021-03-03 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +25,930 | -$89.5K | EDGAR |
| 2021-02-19 | ANTARES PHARMA, INC. (ATRS) Delisted | Mixed | +44,536 | -$169.5K | EDGAR |
| 2020-11-16 | ANTARES PHARMA, INC. (ATRS) Delisted | Buy (P) | +16,400 | $46.7K | EDGAR |